Coated Endotracheal Tube Market by Intubation (Orotracheal and Nasotracheal Intubation), Application (Anesthesia, Emergency Medicine, and Others), and End User (Hospital, Clinics, and Ambulatory Surgical Centers [ASCs]) - Global Opportunities and Forecasts, 2017-2023 Update Available On-Demand
|
LI_183622
|
Pages: 180
|
Jan
2018 |
4604 Views
|
|
|
|
Author(s) :
Pallavi Jaiswal & Mayuri Srivastava
|
Tables: 117
|
Charts: 37
|
Formats*:
|
|
Coated Endotracheal Tube Market Overview:
The Global Coated Endotracheal Tube Market was valued at $1,629 million in 2016, and is estimated to reach $2,518 million at a CAGR of 6.3% from 2017 to 2023. Endotracheal tubes are medical devices used for intubation into the trachea to maintain an open airway and to administer certain drugs. There are used for mechanical ventilation, thus there is risk for microbial invasion into the airways. Therefore, to prevent or reduce the incidence of hospital acquired infection or ventilator-associated pneumonia (VAP), endotracheal tubes are coated with a drug-releasing coating that releases antimicrobial agents to inhibit bacterial growth and biofilm formation. Coated endotracheal tube includes variety of endotracheal tubes coated with drugs or materials, which offer antimicrobial properties to endotracheal tube. Coatings include heparin, silver, chlorhexidine, rifampicin, and minocycline agents.
Advantages of Coated Endotracheal Tubes
Coated endotracheal tubes are advantageous because coatings have a broad-spectrum antimicrobial activity in vitro, that reduces bacterial adhesion and restricts the biofilm formation on the tube surface. This in turn blocks the occurrence of type of hospital-associated infection called ventilator-associated pneumonia. Ventilator-associated pneumonia (VAP) is a type of infection that mainly occurs in patients with mechanical ventilation and it is caused due to the growth of microorganism on the surface of air management devices, thereby causing illness. According to the infectious diseases society of America/American thoracic society guidelines, 2016, VAP develops 48‐72 hours after endotracheal intubation. Moreover, VAP affects 28% of patients who are on mechanical ventilation. Therefore, VAP is an important source of morbidity and mortality in critically ill patients. The mortality rate attributed to VAP is 27% and as high as 43% when the causative agent is antibiotic resistant.
Hence, it is important to prevent VAP infections by replacing the non-coated endotracheal tubes with coated endotracheal tubes. Endotracheal tubes if coated with antibiotic agents such as drugs and silver, will prevent the growth of microorganisms during ventilation. Therefore, increase in incidence of VAP is projected to upsurge the need of coated endotracheal tubes, thus boosting the market growth.
Market Segmentation
The global coated endotracheal tube market is segmented based on intubation, application, end user, and region. Based on the intubation, the market is bifurcated into orotracheal intubation and nasotracheal intubation. Based on application, the market is categorized into anesthesia, emergency medicine, and others. Based on end user, the market is classified into hospital, clinics, and ambulatory surgical centers. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Get more information on this report : Request Sample Pages
Segment Review
Orotracheal intubation segment accounted for the largest market share in 2016 and is expected to remain so throughout the forecast period. Orotracheal intubation is a process of passing an endotracheal tube through the mouth to trachea. The tube, which is inserted through mouth is known as orotracheal tube. Orotracheal intubation is less painful and easy to perform. It is mainly used in emergency situations such as cardiac or respiratory arrest, inadequate oxygenation or ventilation, and airway obstruction. Orotracheal intubation is easier to perform, faster and less painful under direct laryngoscopy.
Get more information on this report : Request Sample Pages
Geographic Review
Based on region, the global market is studied across North America, Europe, Asia-Pacific, and LAMEA. North America held the largest share of the market in 2016, followed by Europe. On the other hand, Asia-Pacific is anticipated to be the fastest-growing regional segment during the analysis period. Asia-Pacific presents lucrative opportunities for players operating in the coated endotracheal tubes market, attributable to its high population base, increase in disposable incomes, and improvement in patient awareness about ventilator associated pneumonia. Asia is a large continent, and is a home to some of the world’s highly populous countries. This region has emerged as an epicenter of cancer, lung injuries, and cardiovascular diseases epidemics.
Get more information on this report : Request Sample Pages
The key players of this market include C.R. Bard, Bactiguard Holding AB, Enox Biopharma Inc., Hospiteknik Healthcare, Innovative Surface Technologies, N8 Medical, LLC, Sharklet Technologies, Inc., Sonoma Pharmaceuticals, Inc., Teleflex Incorporated, and Venner Medical International.
Pipeline Analysis
Pipeline products include coated endotracheal tubes developed by major key players that are still in clinical stages. These products are as follows
Company Name | Product Name | Description |
N8 Medical LLC | CeraShield endotracheal tube | CeraShield endotracheal tube is designed to address a myriad of complications in mechanically-ventilated patients. It prevents or reduce microbial colonization and biofilm growth on the tube surface, thereby reducing length of hospital stay and risk of infection and death. |
Innovative Surface Technologies, Inc. | ISurTec Endotracheal tubes (Clinical phase 1) | ISurTec is developing a drug-releasing superhydrophobic coating for endotracheal tubes prevents or reduce the incidence of ventilator associated pneumonia. |
Sharklet Technologies | Micropatterned Endotracheal Tubes | Micropatterned endotracheal tubes reduce the accumulation of normal airway secretion and improve patient care. |
Key Benefits
- The study provides an in-depth analysis of the global coated endotracheal tubes market with current trends and future estimations from 2016 to 2023 to elucidate the imminent investment pockets.
- Comprehensive analysis of factors that drive and restrict the market growth is provided.
- Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global & regional scale are provided.
- Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the market.
Coated Endotracheal Tube Market Key Segments:
By Intubation
- Orotracheal Intubation
- Nasotracheal Intubation
By Application
- Anesthesia
- Emergency Medicine
- Others
By End User
- Hospitals
- Clinics
- Ambulatory Surgical Centers
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
CHAPTER 1: Introduction
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: Executive summary
2.1. Key findings of the study
2.1.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.2.2.1. Competitive intelligence and strategies of companies
3.3. Top player positioning
3.4. Coated endotracheal tubes key facts
3.4.1. Metallic coated endotracheal tubes
3.4.2. Non-metallic coated endotracheal tubes
3.4.3. Pipeline Products
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Rise in number of surgical procedures across the globe
3.5.1.2. Large pool of geriatric population and related rise in chronic diseases
3.5.1.3. Advantages of coated endotracheal tubes
3.5.2. Restraints
3.5.2.1. Dearth of skilled professionals
3.5.2.2. Post-operative risks associated with laparoscopy surgeries
3.5.3. Opportunities
3.5.3.1. Emerging economies
3.5.3.2. Technological advancement in endotracheal tubes
3.5.4. Impact analysis
CHAPTER 4: coated endotracheal tub MARKET, BY intubation
4.1. Overview
4.1.1. Market size and forecast
4.2. Orotracheal Intubation
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market size and forecast, by country
4.3. Nasotracheal Intubation
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market size and forecast, by country
CHAPTER 5: coated endotracheal tubed MARKet BY application
5.1. Overview
5.1.1. Market size and forecast
5.2. Anesthesia
5.2.1. Market size and forecast, by region
5.2.2. Market size and forecast, by country
5.3. Emergency Medicine
5.3.1. Market size and forecast, by region
5.3.2. Market size and forecast, by country
5.4. Other Applications
5.4.1. Market size and forecast, by region
5.4.2. Market size and forecast, by country
CHAPTER 6: coated endotracheal tubes MARKet BY end user
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Market size and forecast, by region
6.2.2. Market size and forecast, by country
6.3. Clinics
6.3.1. Market size and forecast, by region
6.3.2. Market size and forecast, by country
6.4. Ambulatory surgical centers (ASCs)
6.4.1. Market size and forecast, by region
6.4.2. Market size and forecast, by country
CHAPTER 7: coated endotracheal tubes MARKet BY Geography
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. North America coated endotracheal tubes market, by country
7.2.2.1. U.S.
7.2.2.1.1. U.S. coated endotracheal tubes market, by intubation
7.2.2.1.2. U.S. coated endotracheal tubes market, by application
7.2.2.1.3. U.S. coated endotracheal tubes market, by end user
7.2.2.2. Canada
7.2.2.2.1. Canada coated endotracheal tubes market, by intubation
7.2.2.2.2. Canada coated endotracheal tubes market, by application
7.2.2.2.3. Canada coated endotracheal tubes market, by end user
7.2.2.3. Mexico
7.2.2.3.1. Mexico coated endotracheal tubes market, by intubation
7.2.2.3.2. Mexico coated endotracheal tubes market, by application
7.2.2.3.3. Mexico coated endotracheal tubes market, by end user
7.2.3. North America coated endotracheal tubes market, by intubation
7.2.4. North America coated endotracheal tubes market, by application
7.2.5. North America coated endotracheal tubes market, by end user
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Europe coated endotracheal tubes market, by country
7.3.2.1. Germany
7.3.2.1.1. Germany coated endotracheal tubes market, by intubation
7.3.2.1.2. Germany coated endotracheal tubes market, by application
7.3.2.1.3. Germany coated endotracheal tubes market, by end user
7.3.2.2. France
7.3.2.2.1. France coated endotracheal tubes market, by intubation
7.3.2.2.2. France coated endotracheal tubes market, by application
7.3.2.2.3. France coated endotracheal tubes market, by end user
7.3.2.3. UK
7.3.2.3.1. UK coated endotracheal tubes market, by intubation
7.3.2.3.2. UK coated endotracheal tubes market, by application
7.3.2.3.3. UK coated endotracheal tubes market, by end user
7.3.2.4. Italy
7.3.2.4.1. Italy coated endotracheal tubes market, by intubation
7.3.2.4.2. Italy coated endotracheal tubes market, by application
7.3.2.4.3. Italy coated endotracheal tubes market, by end user
7.3.2.5. Spain
7.3.2.5.1. Spain coated endotracheal tubes market, by intubation
7.3.2.5.2. Spain coated endotracheal tubes market, by application
7.3.2.5.3. Spain coated endotracheal tubes market, by end user
7.3.2.6. Rest of Europe
7.3.2.6.1. Rest of Europe coated endotracheal tubes market, by intubation
7.3.2.6.2. Rest of Europe coated endotracheal tubes market, by application
7.3.2.6.3. Rest of Europe coated endotracheal tubes market, by end user
7.3.3. Europe coated endotracheal tubes market, by intubation
7.3.4. Europe coated endotracheal tubes market, by application
7.3.5. Europe coated endotracheal tubes market, by end user
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Asia-Pacific coated endotracheal tubes market, by country
7.4.2.1. Japan
7.4.2.1.1. Japan coated endotracheal tubes market, by intubation
7.4.2.1.2. Japan coated endotracheal tubes market, by application
7.4.2.1.3. Japan coated endotracheal tubes market, by end user
7.4.2.2. China
7.4.2.2.1. China coated endotracheal tubes market, by intubation
7.4.2.2.2. China coated endotracheal tubes market, by application
7.4.2.2.3. China coated endotracheal tubes market, by end user
7.4.2.3. India
7.4.2.3.1. India coated endotracheal tubes market, by intubation
7.4.2.3.2. India coated endotracheal tubes market, by application
7.4.2.3.3. India coated endotracheal tubes market, by end user
7.4.2.4. Australia
7.4.2.4.1. Australia coated endotracheal tubes market, by intubation
7.4.2.4.2. Australia coated endotracheal tubes market, by application
7.4.2.4.3. Australia coated endotracheal tubes market, by end user
7.4.2.5. South Korea
7.4.2.5.1. South Korea coated endotracheal tubes market, by intubation
7.4.2.5.2. South Korea coated endotracheal tubes market, by application
7.4.2.5.3. South Korea coated endotracheal tubes market, by end user
7.4.2.6. Rest of Asia-Pacific
7.4.2.6.1. Rest of Asia-Pacific coated endotracheal tubes market, by intubation
7.4.2.6.2. Rest of Asia-Pacific coated endotracheal tubes market, by application
7.4.2.6.3. Rest of Asia-Pacific coated endotracheal tubes market, by end user
7.4.3. Asia-Pacific coated endotracheal tubes market, by intubation
7.4.4. Asia-Pacific coated endotracheal tubes market, by application
7.4.5. Asia-Pacific coated endotracheal tubes market, by end user
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. LAMEA coated endotracheal tubes market, by country
7.5.2.1. Brazil
7.5.2.1.1. Brazil coated endotracheal tubes market, by intubation
7.5.2.1.2. Brazil coated endotracheal tubes market, by application
7.5.2.1.3. Brazil coated endotracheal tubes market, by end user
7.5.2.2. Saudi Arabia
7.5.2.2.1. Saudi Arabia coated endotracheal tubes market, by intubation
7.5.2.2.2. Saudi Arabia coated endotracheal tubes market, by application
7.5.2.2.3. Saudi Arabia coated endotracheal tubes market, by end user
7.5.2.3. South Africa
7.5.2.3.1. South Africa coated endotracheal tubes market, by intubation
7.5.2.3.2. South Africa coated endotracheal tubes market, by application
7.5.2.3.3. South Africa coated endotracheal tubes market, by end user
7.5.2.4. Rest of LAMEA
7.5.2.4.1. Rest of LAMEA coated endotracheal tubes market, by intubation
7.5.2.4.2. Rest of LAMEA coated endotracheal tubes market, by application
7.5.2.4.3. Rest of LAMEA coated endotracheal tubes market, by end user
7.5.3. LAMEA coated endotracheal tubes market, by intubation
7.5.4. LAMEA coated endotracheal tubes market, by application
7.5.5. LAMEA coated endotracheal tubes market, by end user
CHAPTER 8: Company profiles
8.1. Bactiguard Holding AB
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. C. R. Bard, Inc.
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.2.6. Key strategic moves and developments
8.3. Enox Biopharma Inc.
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.4. Hospiteknik Healthcare
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating product segments
8.4.4. Product portfolio
8.5. Innovative Surface Technologies, Inc.
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating product segments
8.5.4. Product portfolio
8.6. N8 Medical, LLC
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating product segments
8.6.4. Product portfolio
8.6.5. Key strategic moves and developments
8.7. Sharklet Technologies, Inc.
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating product segments
8.7.4. Product portfolio
8.8. Sonoma Pharmaceuticals Inc.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating product segments
8.8.4. Product portfolio
8.8.5. Business performance
8.9. Teleflex Incorporated
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments
8.10. Venner Medical GmbH
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating product segments
8.10.4. Product portfolio
LIST OF TABLES
TABLE 01. PRODUCT PIPELINE
TABLE 02. POPULATION STATISTICS OF 2000, 2015, AND 2030- BY AGE (MILLIONS)
TABLE 03. HEALTHCARE EXPENDITURE OF FEW ASIA-PACIFIC COUNTRIES (2015)
TABLE 04. GLOBAL COATED ENDOTRACHEAL TUBES MARKET, BY INTUBATION, 2016-2023 ($MILLION)
TABLE 05. COATED ENDOTRACHEAL TUBES MARKET FOR OROTRACHEAL INTUBATION, BY REGION, 2016-2023 ($MILLION)
TABLE 06. COATED ENDOTRACHEAL TUBES MARKET FOR NASOTRACHEAL INTUBATION, BY REGION, 2016-2023 ($MILLION)
TABLE 07. GLOBAL COATED ENDOTRACHEAL TUBES MARKET REVENUE, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 08. COATED ENDOTRACHEAL TUBES MARKET FOR ANESTHESIA, BY REGION, 2016-2023 ($MILLION)
TABLE 09. COATED ENDOTRACHEAL TUBES MARKET FOR EMERGENCY MEDICINE, BY REGION, 2016-2023 ($MILLION)
TABLE 10. COATED ENDOTRACHEAL TUBES MARKET FOR OTHER APPLICATIONS, BY REGION, 2016-2023 ($MILLION)
TABLE 11. GLOBAL COATED ENDOTRACHEAL TUBES MARKET REVENUE, BY END USER, 2016-2023 ($MILLION)
TABLE 12. COATED ENDOTRACHEAL TUBES MARKET FOR HOSPITALS, BY REGION, 2016-2023 ($MILLION)
TABLE 13. COATED ENDOTRACHEAL TUBES MARKET FOR CLINICS, BY REGION, 2016-2023 ($MILLION)
TABLE 14. COATED ENDOTRACHEAL TUBES MARKET FOR AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2016-2023 ($MILLION)
TABLE 15. GLOBAL COATED ENDOTRACHEAL TUBES MARKET REVENUE, BY REGION, 2016-2023 ($MILLION)
TABLE 16. NORTH AMERICA COATED ENDOTRACHEAL TUBES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 17. U.S. COATED ENDOTRACHEAL TUBES MARKET, BY INTUBATION, 2016-2023 ($MILLION)
TABLE 18. U.S. COATED ENDOTRACHEAL TUBES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 19. U.S. COATED ENDOTRACHEAL TUBES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 20. CANADA COATED ENDOTRACHEAL TUBES MARKET, BY INTUBATION, 2016-2023 ($MILLION)
TABLE 21. CANADA COATED ENDOTRACHEAL TUBES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 22. CANADA COATED ENDOTRACHEAL TUBES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 23. MEXICO COATED ENDOTRACHEAL TUBES MARKET, BY INTUBATION, 2016-2023 ($MILLION)
TABLE 24. MEXICO COATED ENDOTRACHEAL TUBES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 25. MEXICO COATED ENDOTRACHEAL TUBES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 26. NORTH AMERICA COATED ENDOTRACHEAL TUBES MARKET, BY INTUBATION, 2016-2023 ($MILLION)
TABLE 27. NORTH AMERICA COATED ENDOTRACHEAL TUBES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 28. NORTH AMERICA COATED ENDOTRACHEAL TUBES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 29. EUROPE COATED ENDOTRACHEAL TUBES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 30. GERMANY COATED ENDOTRACHEAL TUBES MARKET, BY INTUBATION, 2016-2023 ($MILLION)
TABLE 31. GERMANY COATED ENDOTRACHEAL TUBES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 32. GERMANY COATED ENDOTRACHEAL TUBES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 33. FRANCE COATED ENDOTRACHEAL TUBES MARKET, BY INTUBATION, 2016-2023 ($MILLION)
TABLE 34. FRANCE COATED ENDOTRACHEAL TUBES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 35. FRANCE COATED ENDOTRACHEAL TUBES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 36. UK COATED ENDOTRACHEAL TUBES MARKET, BY INTUBATION, 2016-2023 ($MILLION)
TABLE 37. UK COATED ENDOTRACHEAL TUBES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 38. UK COATED ENDOTRACHEAL TUBES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 39. ITALY COATED ENDOTRACHEAL TUBES MARKET, BY INTUBATION, 2016-2023 ($MILLION)
TABLE 40. ITALY COATED ENDOTRACHEAL TUBES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 41. ITALY COATED ENDOTRACHEAL TUBES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 42. SPAIN COATED ENDOTRACHEAL TUBES MARKET, BY INTUBATION, 2016-2023 ($MILLION)
TABLE 43. SPAIN COATED ENDOTRACHEAL TUBES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 44. SPAIN COATED ENDOTRACHEAL TUBES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 45. REST OF EUROPE COATED ENDOTRACHEAL TUBES MARKET, BY INTUBATION, 2016-2023 ($MILLION)
TABLE 46. REST OF EUROPE COATED ENDOTRACHEAL TUBES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 47. REST OF EUROPE COATED ENDOTRACHEAL TUBES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 48. EUROPE COATED ENDOTRACHEAL TUBES MARKET, BY INTUBATION, 2016-2023 ($MILLION)
TABLE 49. EUROPE COATED ENDOTRACHEAL TUBES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 50. EUROPE COATED ENDOTRACHEAL TUBES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 51. ASIA-PACIFIC COATED ENDOTRACHEAL TUBES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 52. JAPAN COATED ENDOTRACHEAL TUBES MARKET, BY INTUBATION, 2016-2023 ($MILLION)
TABLE 53. JAPAN COATED ENDOTRACHEAL TUBES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 54. JAPAN COATED ENDOTRACHEAL TUBES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 55. CHINA COATED ENDOTRACHEAL TUBES MARKET, BY INTUBATION, 2016-2023 ($MILLION)
TABLE 56. CHINA COATED ENDOTRACHEAL TUBES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 57. CHINA COATED ENDOTRACHEAL TUBES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 58. INDIA COATED ENDOTRACHEAL TUBES MARKET, BY INTUBATION, 2016-2023 ($MILLION)
TABLE 59. INDIA COATED ENDOTRACHEAL TUBES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 60. INDIA COATED ENDOTRACHEAL TUBES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 61. AUSTRALIA COATED ENDOTRACHEAL TUBES MARKET, BY INTUBATION, 2016-2023 ($MILLION)
TABLE 62. AUSTRALIA COATED ENDOTRACHEAL TUBES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 63. AUSTRALIA COATED ENDOTRACHEAL TUBES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 64. SOUTH KOREA COATED ENDOTRACHEAL TUBES MARKET, BY INTUBATION, 2016-2023 ($MILLION)
TABLE 65. SOUTH KOREA COATED ENDOTRACHEAL TUBES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 66. SOUTH KOREA COATED ENDOTRACHEAL TUBES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 67. REST OF ASIA-PACIFIC COATED ENDOTRACHEAL TUBES MARKET, BY INTUBATION, 2016-2023 ($MILLION)
TABLE 68. REST OF ASIA-PACIFIC COATED ENDOTRACHEAL TUBES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 69. REST OF ASIA-PACIFIC COATED ENDOTRACHEAL TUBES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 70. ASIA-PACIFIC COATED ENDOTRACHEAL TUBES MARKET, BY INTUBATION, 2016-2023 ($MILLION)
TABLE 71. ASIA-PACIFIC COATED ENDOTRACHEAL TUBES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 72. ASIA-PACIFIC COATED ENDOTRACHEAL TUBES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 73. LAMEA COATED ENDOTRACHEAL TUBES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 74. BRAZIL COATED ENDOTRACHEAL TUBES MARKET, BY INTUBATION, 2016-2023 ($MILLION)
TABLE 75. BRAZIL COATED ENDOTRACHEAL TUBES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 76. BRAZIL COATED ENDOTRACHEAL TUBES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 77. SAUDI ARABIA COATED ENDOTRACHEAL TUBES MARKET, BY INTUBATION, 2016-2023 ($MILLION)
TABLE 78. SAUDI ARABIA COATED ENDOTRACHEAL TUBES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 79. SAUDI ARABIA COATED ENDOTRACHEAL TUBES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 80. SOUTH AFRICA COATED ENDOTRACHEAL TUBES MARKET, BY INTUBATION, 2016-2023 ($MILLION)
TABLE 81. SOUTH AFRICA COATED ENDOTRACHEAL TUBES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 82. SOUTH AFRICA COATED ENDOTRACHEAL TUBES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 83. REST OF LAMEA COATED ENDOTRACHEAL TUBES MARKET, BY INTUBATION, 2016-2023 ($MILLION)
TABLE 84. REST OF LAMEA COATED ENDOTRACHEAL TUBES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 85. REST OF LAMEA COATED ENDOTRACHEAL TUBES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 86. LAMEA COATED ENDOTRACHEAL TUBES MARKET, BY INTUBATION, 2016-2023 ($MILLION)
TABLE 87. LAMEA COATED ENDOTRACHEAL TUBES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 88. LAMEA COATED ENDOTRACHEAL TUBES MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 89. BACTIGUARD HOLDING AB
TABLE 90. BACTIGUARD HOLDING AB: OPERATING SEGMENTS
TABLE 91. BACTIGUARD HOLDING AB: PRODUCT PORTFOLIO
TABLE 92. C. R. BARD, INC.
TABLE 93. C. R. BARD, INC.: OPERATING SEGMENTS
TABLE 94. C. R. BARD, INC.: PRODUCT PORTFOLIO
TABLE 95. ENOX BIOPHARMA INC.
TABLE 96. ENOX BIOPHARMA INC.: PRODUCT PORTFOLIO
TABLE 97. HOSPITEK HEALTHCARE: COMPANY SNAPSHOT
TABLE 98. HOSPITEK HEALTHCARE: PRODUCT SEGMENTS
TABLE 99. ENOX BIOPHARMA INC.: PRODUCT PORTFOLIO
TABLE 100. ISURTEC: COMPANY SNAPSHOT
TABLE 101. ISURTEC: PRODUCTS SEGMENTS
TABLE 102. ISURTEC: PRODUCTS PORTFOLIO
TABLE 103. N8 MEDICAL LLC: COMPANY SNAPSHOT
TABLE 104. N8 MEDICAL LLC: PRODUCT SEGMENTS
TABLE 105. N8 MEDICAL: PRODUCTS PORTFOLIO
TABLE 106. SHARKLET TECHNOLOGIES: COMPANY SNAPSHOT
TABLE 107. N8 MEDICAL LLC: PRODUCT SEGMENTS
TABLE 108. SHARKLET TECHNOLOGIES: PRODUCTS PORTFOLIO
TABLE 109. SONOMA PHARMACEUTICALS: COMPANY SNAPSHOT
TABLE 110. SONOMA PHARMACEUTICALS: PRODUCT SEGMENTS
TABLE 111. SONOMA PHARMACEUTICALS: PRODUCTS PORTFOLIO
TABLE 112. TELEFLEX: COMPANY SNAPSHOT
TABLE 113. TELEFLEX: OPERATING SEGMENTS
TABLE 114. TELEFLEX: PRODUCT PORTFOLIO
TABLE 115. VENNER MEDICAL: COMPANY SNAPSHOT
TABLE 116. VENNER MEDICAL: PRODUCT SEGMENTS
TABLE 117. VENNER MEDICAL: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01. COATED ENDOTRACHEAL TUBES MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS IN THE GLOBAL COATED ENDOTRACHEAL TUBES MARKET
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2014-2017
FIGURE 04. TOP WINNING STRATEGIES, 2016-2023 (%)
FIGURE 05. TOP COMPANIES AND THEIR STRATEGIES, 2014-2017
FIGURE 06. TOP PLAYER POSITIONING, 2016
FIGURE 07. TEN LEADING CANCER TYPES FOR THE ESTIMATED NEW CANCER CASES, U.S., 2015
FIGURE 08. TOP INVESTMENT POCKETS IN THE GLOBAL COATED ENDOTRACHEAL TUBES MARKET
FIGURE 09. GLOBAL COATED ENDOTRACHEL TUBE MARKET, BY INTUBATION, 2016-2023
FIGURE 10. COMPARATIVE REGIONAL ANALYSIS OF OROTRACHEAL INTUBATION MARKET, 2023 ($MILLION)
FIGURE 11. COMPARATIVE REGIONAL ANALYSIS OF NASOTRACHEAL INTUBATION MARKET, 2023 ($MILLION)
FIGURE 12. GLOBAL COATED ENDOTRACHEL TUBE MARKET, BY APPLICATION, 2016-2023
FIGURE 13. COMPARATIVE REGIONAL ANALYSIS OF ANESTHESIA MARKET, 2023 ($MILLION)
FIGURE 14. COMPARATIVE REGIONAL ANALYSIS OF EMERGENCY MEDICINE MARKET, 2023 ($MILLION)
FIGURE 15. COMPARATIVE REGIONAL ANALYSIS OF OTHER APPLICATIONS MARKET, 2023 ($MILLION)
FIGURE 16. GLOBAL COATED ENDOTRACHEAL TUBE MARKET, BY END USER, 2016-2023
FIGURE 17. COMPARATIVE REGIONAL ANALYSIS OF HOSPITALS MARKET, 2023 ($MILLION)
FIGURE 18. COMPARATIVE REGIONAL ANALYSIS OF CLINICS MARKET, 2023 ($MILLION)
FIGURE 19. COMPARATIVE REGIONAL ANALYSIS OF AMBULATORY SURGICAL CENTERS (ASCS) MARKET, 2023 ($MILLION)
FIGURE 20. NORTH AMERICA COATED ENDOTRACHEAL TUBES MARKET, 2016-2023
FIGURE 21. AGE ADJUSTED PERCENTAGE OF SELECTED RESPIRATORY DISEASES AMONG ADULTS AGED 18 AND OVER, U.S. IN 2015
FIGURE 22. EUROPEAN COATED ENDOTRACHEAL TUBES MARKET, 2016-2023
FIGURE 23. LUNG CANCER INCIDENCE IN EUROPEAN REGION BY GENDER, 2012 (PER 100,000 POPULATION)
FIGURE 24. ASIA-PACIFIC COATED ENDOTRACHEAL TUBES MARKET, 2016-2023
FIGURE 25. PREVALENCE OF CORONARY ARTERY DISEASE IN INDIA BY AGE, 2010 & 2015 (IN MILLIONS)
FIGURE 26. LAMEA COATED ENDOTRACHEAL TUBES MARKET, 2016-2023
FIGURE 27. TOTAL ELDERLY POPULATION IN BRAZIL, 2009-2013 (IN PERCENTAGE)
FIGURE 28. BACTIGUARD HOLDING AB: NET SALES, 2014-2016 ($MILLION)
FIGURE 29. BACTIGUARD HOLDING AB: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 30. C. R. BARD, INC.: NET SALES, 2014-2016 ($MILLION)
FIGURE 31. C. R. BARD, INC.: REVENUE SHARE BY BUSINESS SEGMENT, 2016 (%)
FIGURE 32. C. R. BARD, INC.: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 33. SONOMA PHARMACEUTICALS: NET SALES, 2014-2016 ($MILLION)
FIGURE 34. SONOMA PHARMACEUTICALS: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 35. TELEFLEX: NET SALES, 2014-2016 ($MILLION)
FIGURE 36. TELEFLEX: REVENUE SHARE BY BUSINESS SEGMENT, 2016 (%)
FIGURE 37. TELEFLEX: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
The adoption of endotracheal tubes is expected to increase due to rise in various types of chronic diseases such as cardiovascular disorders and diabetes. These tubes provide proper airway management during surgical procedures and prevent airway obstruction.
Upsurge in cases of chronic diseases and increase in prevalence of diabetes make it imperative to use endotracheal tubes during intubation processes or surgeries. Moreover, increase in prevalence of ventilator associated pneumonia, advantages of coated endotracheal tubes with lesser side effects, rise in geriatric population, and surge in affordability in the developing economies are projected to supplement the market growth. However, complications associated with these tubes and dearth of skilled professionals are expected to impede the market growth.
The use of coated endotracheal tubes is highest in North America, owing to increased usage of endotracheal intubation and heavy expenditure by the government on healthcare, followed by Europe and Asia-Pacific. In addition, coated endotracheal tubes providers and distributors have focused on expanding their presence in the emerging economies, which is anticipated to drive the market growth.
Download Sample
Purchase Full Report of
Coated Endotracheal Tube Market- Global
Opportunities and Forecasts, 2017-2023
- Online Only
- $3,217
- Online cloud access only
- Restricted print, copy, paste & download
- Read only
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Data Pack
- $3,574
- Restricted to one authorized user
- One print only
- Available in
Excel - Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Single User
- $4,999
- Restricted to one authorized user
- One print only
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Five Users
- $6,004
- Limited to five authorized users
- Print upto five copies
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
-
Enterprise
License/PDF - $8,373
- Unlimited
within
company/enterprise - Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Library Membership
- $0.00
- Published Content
E-access - Company Profiles
E-access - Newly Added Content Access
- 10 PDF
Downloads - 5 Excel Data
Pack Downloads - 250 Company Profiles PDF Downloads
-
Start reading instantly.
Buy Now
This title and over 12,000+ are available on the Avenue Library. Subscription @ $559 T&C*.
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
Why Allied Market Research?
Infallible Methodology
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
Analyst Support
For complete satisfaction
Customization
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET VIEW
Targeted market view to provide pertinent information and save time of readers
Get fresh content delivered
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.